M. D’Arcangelo

1.6k citations
32 papers · 395 · h-index 13

Impact in

    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Cancer Cells and Metastasis
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Prostate Cancer Treatment and Research

Papers in

    • Lung Cancer Treatments and Mutations 20
    • Lung Cancer Diagnosis and Treatment 3
    • Ferroptosis and cancer prognosis 2
    • Cancer Immunotherapy and Biomarkers 9
    • Lung Cancer Research Studies 8
    • Colorectal Cancer Treatments and Studies 3

M. D’Arcangelo

31 papers receiving 386 citations

Peers

M. D’Arcangelo
Comparison fields: 5 of 57
  • Oncology 182
  • Pulmonary and Respiratory Medicine 170
  • Cancer Research 74
  • Hepatology 28
  • Immunology 40
Replace Lingzhi Hong with:
Lingzhi Hong United States
Hongge Liang China
Chester Kao United States
Guo Long China
Danmei Pang China
Peter Schirmacher Germany
Davide Bosso Italy
Katherine Minichiello United States
Trine Lindsted United States
Lan-ying Gou China
M. D’Arcangelo relative to Lingzhi Hong United States Lingzhi Hong's profile →
Citations per field
00.5×1.5×2.1×
Lingzhi Hong · 1×
Citations per year

Countries citing papers authored by M. D’Arcangelo

Since Specialization
Citations

This map shows the geographic impact of M. D’Arcangelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. D’Arcangelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. D’Arcangelo more than expected).

Fields of papers citing papers by M. D’Arcangelo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. D’Arcangelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. D’Arcangelo. The network helps show where M. D’Arcangelo may publish in the future.

Co-authors

The 25 scholars most cited alongside M. D’Arcangelo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. D’Arcangelo Line = papers co-authored together M. D’Arcangelo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200976
2 201336
3 202430
4 201427
5 201825
6 201223
7 201319
8 202017
9 201316
10 202215
11 201915
12 201513
13 201412
14 201911
15 201611
16 201310
17 20199
18 20215
19 20125
20 20104

About M. D’Arcangelo

M. D’Arcangelo is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 32 papers that have together received 395 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (20 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Research Studies (8 papers), Lung Cancer Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer therapeutics and mechanisms (3 papers), Ferroptosis and cancer prognosis (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (182 citations), Pulmonary and Respiratory Medicine (170 citations), Cancer Research (74 citations), Hepatology (28 citations) and Immunology (40 citations). M. D’Arcangelo has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Federico Cappuzzo, Fred R. Hirsch, Lorenza Landi, Armida D’Incecco, Luca Galli, Giacomo Allegrini, Andrea Antonuzzo, Romano Danesi, C. Galli and R. Di Marsico. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Journal of Clinical Oncology, Oncotarget and Future Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact